Prospect: information for the patient
Losartán/Hidroclorotiazida Sandoz 100 mg/25 mg film-coated tablets EFG
Read this prospect carefully before starting to take the medicine, as it contains important information for you.
1.What is Losartán/Hidroclorotiazida Sandoz and how is it used
2.What you need to know before starting to take Losartán/Hidroclorotiazida Sandoz
3.How to take Losartán/Hidroclorotiazida Sandoz
4.Possible adverse effects
5.Storage of Losartán/Hidroclorotiazida Sandoz
6.Contents of the package and additional information
Losartan potassium belongs to a group of medicines called angiotensin-II receptor antagonists. These cause the relaxation of blood vessels, which leads to a decrease in blood pressure.
Hidroclorotiazida belongs to a group of medicines called diuretics. Hidroclorotiazida causes the kidneys to eliminate a greater amount of salts. This also helps to reduce blood pressure.
Losartán/Hidroclorotiazida 100 mg/25 mg is used to treat high blood pressure in patients who do not respond sufficiently to treatment with losartan/hidroclorotiazida 50 mg/12.5 mg.
Do not take Losartán/Hidroclorotiazida Sandoz:
If you think any of the above conditions may apply to you, consult your doctor or pharmacist.
Warnings and precautions
Consult your doctor or pharmacist before starting to take Losartán/Hidroclorotiazida Sandoz.
You must inform your doctor if you think you may be pregnant. Losartan/hydrochlorothiazide is not recommended at the beginning of pregnancy and should not be used if you are more than 3 months pregnant, as it may cause serious harm to your baby if used in this stage (see Pregnancy section).
It is important to inform your doctor before taking Losartán/Hidroclorotiazida Sandoz:
Consult your doctor if you experience abdominal pain, nausea, vomiting, or diarrhea after taking losartan/hydrochlorothiazide. Your doctor will decide whether to continue treatment. Do not stop taking losartan/hydrochlorothiazide on your own.
Your doctor may monitor your kidney function, blood pressure, and electrolyte levels in your blood (e.g. potassium) at regular intervals.
See also the information under the heading “Do not take Losartán/Hidroclorotiazida Sandoz”.
Children and adolescents
The safety and efficacy of losartan/hydrochlorothiazide have not been established in children and adolescents under 18 years of age. Losartan/hydrochlorothiazide should not be given to children and adolescents.
Ask your doctor if you are subject to adrug testas losartan/hydrochlorothiazide contains an active substance that may give a positive result in a drug test.
Other medicines and Losartán/Hidroclorotiazida Sandoz
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medicine.
Your doctor may need to adjust your dose and/or take other precautions if you are taking:
Please inform your doctor if you are taking losartan/hydrochlorothiazide and are to undergo a radiographic procedure and need to take a contrast agent containing iodine.
Losartán/Hidroclorotiazida Sandoz with food and drink
It is recommended that you do not drink alcohol while taking these tablets: alcohol and losartan/hydrochlorothiazide tablets may increase the effects of both.
Excessive salt in the diet may counteract the effect of losartan/hydrochlorothiazide.
Losartan/hydrochlorothiazide can be taken with or without food.
Pregnancy and breastfeeding
Pregnancy
You must inform your doctor if you think you may be pregnant. Normally, your doctor will advise you to stop taking losartan/hydrochlorothiazide before becoming pregnant or as soon as you know you are pregnant and will advise you to take a different medicine instead of losartan/hydrochlorothiazide. Losartan/hydrochlorothiazide is not recommended at the beginning of pregnancy and should not be taken if you are more than 3 months pregnant, as it may cause serious harm to your baby if used from the third month of pregnancy.
Lactation
Consult your doctor if you are breastfeeding or plan to start. Losartan/hydrochlorothiazide is not recommended for breastfeeding mothers and your doctor may choose a different treatment if you wish to breastfeed.
If you are pregnant or breastfeeding, or think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
Driving and using machines
When starting treatment with this medicine, you should not perform tasks that require special attention (e.g. driving a car or using hazardous machinery) until you know how your medicine affects you.
Losartán/Hidroclorotiazida Sandoz contains lactose.
If your doctor has told you that you are intolerant to certain sugars, consult with him before taking this medicine.
Follow exactly the administration instructions of this medication as indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.Your doctor will decide the appropriate dose of losartan/hydrochlorothiazide based on your condition and if you are taking other medications.It is essential to continue taking losartan/hydrochlorothiazide as prescribed by your doctor to maintain constant blood pressure control.
Take the tablet with a glass of water. It can be taken with or without food.
Use in adults
The usual dose of losartan/hydrochlorothiazide 100 mg/25 mg is one tablet once a day.
Use in elderly patients
Generally, no dose adjustment is necessary in elderly patients.
Use in hemodialysis and renal insufficiency
In cases of moderate kidney problems, generally no dose adjustment is necessary. Do not take losartan/hydrochlorothiazide if you have severe kidney insufficiency. Losartan/hydrochlorothiazide is not recommended in patients undergoing hemodialysis.
Use in liver insufficiency
Losartan/hydrochlorothiazide should be used with caution in patients with a history of mild to moderate liver insufficiency.
Do not take losartan/hydrochlorothiazide if your liver function is severely impaired (see section 2 “Do not take Losartan/Hydrochlorothiazide Sandoz”).
Use in children and adolescents
Losartan/hydrochlorothiazide should not be administered to children and adolescents under 18 years of age.
Use in black patients
A dose adjustment may be necessary as the effectiveness may be reduced in black patients compared to non-black patients.
If you take moreLosartan/Hydrochlorothiazide Sandozthan you should
In case of an overdose, contact your doctor immediately for immediate medical attention. An overdose may cause a drop in blood pressure, palpitations, slow pulse, changes in blood composition, and dehydration..If you have taken more Losartan/Hydrochlorothiazide Sandoz than you should, consult your doctor, pharmacist, or call the Toxicological Information Service, phone: 91 562 04 20, indicating the medication and the amount used..
If you forgot to takeLosartan/Hydrochlorothiazide Sandoz
Do not take a double dose to compensate for the missed doses. Take your next dose as usual.
If you interrupt the treatment withLosartan/Hydrochlorothiazide Sandoz
Always consult your doctor if you want to stop taking this medication. Although you may feel well, it may be necessary to continue taking this medication.
If you have any other questions about the use of thismedication, ask your doctororpharmacist.
Like all medicines, this medicine may cause side effects, although not everyone will experience them.
If you experience any of the following, stop taking losartan/hydrochlorothiazide tablets and inform your doctor immediately or go to the emergency service of your nearest hospital:
This is a severe but rare side effect that affects more than 1 in 10,000 patients, but less than 1 in 1,000 patients. You may need urgent medical attention or hospitalization.
Acute respiratory distress (symptoms include severe respiratory difficulty, fever, weakness, and confusion), this is a very rare side effect (it may affect up to 1 in 10,000 people).
The following side effects have been reported:
Frequent(may affect up to 1 in 10 people):
Infrequent(may affect up to 1 in 100 people):
Rare(may affect up to 1 in 1,000 people):
Frequency unknown(the frequency cannot be estimated from the available data):
Reporting of side effects
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect that does not appear in this prospectus. You can also report them directly through theSpanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Do not use Losartán/Hidroclorotiazida Sandoz after the expiration date that appears on the packaging after CAD. The expiration date is the last day of the month indicated.
Alu/Alu Blister: conserve below 30 °C.
Aclar/Alu Blister: conserve below 30 °C
Bottle: keep the bottle perfectly closed to protect it from moisture.
Medicines should not be thrown down the drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE point of the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. In this way, you will help protect the environment.
Composition of Losartán/Hidroclorotiazida Sandoz
Core:lactose monohydrate, microcrystalline cellulose, pregelatinized cornstarch, magnesium stearate, anhydrous colloidal silica.
Covering:hypromellose, hydroxypropylcellulose, yellow iron oxide (E172), titanium dioxide (E171), macrogol (400), talc.
Appearance of the product and contents of the package
Losartán/Hidroclorotiazida Sandoz 100 mg/25 mg is presented as film-coated tablets, are yellowish in color, round, biconvex with a diameter of 10 mm.
It is packaged in aluminum foil blisters or in plastic bottles with or without a child-resistant cap.
Blisters: 7, 10, 14, 28, 30, 50, 56, 60, 84, 90, 98, and 100 film-coated tablets.
Blisters (single dose): 50 film-coated tablets.
Bottles: 100 and 250 film-coated tablets.
Only some package sizes may be marketed.
Marketing authorization holder and responsible manufacturer
Marketing authorization holder
Sandoz Farmacéutica, S.A.
Centro Empresarial Parque Norte
Edificio Roble
C/ Serrano Galvache, 56
28033 Madrid
Spain
Responsible manufacturer
Lek Pharmaceuticals d.d.
Verovskova 57
SI-1526 Ljubljana
Slovenia
or
Lek S.A.,
Ul. Domaniewska 50 C
02-672 Warsaw
Poland
or
Salutas Pharma GmbH
Otto von Guericke Allee 1
39179 Barleben, Germany
or
Salutas Pharma GmbH
Dieselstrasse 5
70839 Gerlingen
Germany
This medicine is authorized in the member states of the European Economic Area and in the United Kingdom (Northern Ireland)with the following names:
Germany:Losartán-HCT Sandoz 100 mg/25 mg Filmtabletten
Austria:Losartán-HCT Sandoz 100 mg/25 mg - Filmtabletten
Belgium:Co-Losartán Sandoz 100 mg/25 mg filmomhulde tabletten
Denmark:Ancozan Comp
France:LOSARTÁN/ HYDROCHLOROTHIAZIDE Sandoz 100 mg/25 mg, comprimé pelliculé
Netherlands:KaliumLosartán/Hydrochloorthiazide Sandoz 100/25 mg, filmomhulde tabletten
Italy:LOSARTÁN IDROCLOROTIAZIDE SANDOZ 100 mg + 25 mg compresse rivestite con film
Portugal:Losartán + Hidroclorotiazida Sintano
United Kingdom (Northern Ireland):Losartán Potassium/Hydrochlorothiazide 100 mg/25 mg Film-coated Tablets
Czech Republic:Sangona COMBI 100 mg/25 mg
Sweden:Losartan/Hydrochlorothiazide Sandoz 100 mg/25 mg filmdragerade tabletter
Last review date of this leaflet: February 2025
Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Medical Devices (AEMPS) http://www.aemps.gob.es
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.